Free Trial

Jyong Biotech (MENS) Institutional Ownership

Jyong Biotech logo
$2.05 -0.02 (-0.77%)
As of 01:14 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Jyong Biotech (NASDAQ:MENS)

Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$1.11M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$2.30M
Get MENS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Jyong Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

MENS Institutional Buying and Selling by Quarter

Jyong Biotech Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026Millennium Management LLC40,258$159K0.0%+209.4%0.053%
2/18/2026Man Group plc14,222$56K0.0%N/A0.019%
2/12/2026Jane Street Group LLC69,560$275K0.0%N/A0.091%
2/9/2026Geode Capital Management LLC64,382$254K0.0%+19.6%0.085%
1/29/2026 China Universal Asset Management Co. Ltd.12,389$49K0.0%N/A0.016%
11/17/2025Millennium Management LLC13,013$512K0.0%N/A0.017%
11/17/2025Citadel Advisors LLC12,641$498K0.0%-82.2%0.017%
11/13/2025BNP Paribas Financial Markets1,698$67K0.0%N/A0.002%


MENS Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Jyong Biotech shares: Citadel Advisors LLC ($498K), Jane Street Group LLC ($275K), Geode Capital Management LLC ($254K), Millennium Management LLC ($159K), BNP Paribas Financial Markets ($67K), and Man Group plc ($56K), and China Universal Asset Management Co. Ltd. ($49K).Learn more on Jyong Biotech's institutional investors.

The following institutional investors have purchased Jyong Biotech's stock in the last 24 months: Jane Street Group LLC ($69.56K), Millennium Management LLC ($40.26K), Man Group plc ($14.22K), China Universal Asset Management Co. Ltd. ($12.39K), Geode Capital Management LLC ($10.54K), and BNP Paribas Financial Markets ($1.70K).

Institutional investors have bought a total of 148,665 shares in the last 24 months. This purchase volume represents approximately $1.11M in transactions.

The following institutional investors have sold Jyong Biotech stock in the last 24 months: Citadel Advisors LLC ($58.33K).

Institutional investors have sold a total of 58,329 shares in the last 24 months. This volume of shares sold represents approximately $2.30M in transactions.



This page (NASDAQ:MENS) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners